These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37721533)

  • 21. The Role of Cardiolipin in Cardiovascular Health.
    Shen Z; Ye C; McCain K; Greenberg ML
    Biomed Res Int; 2015; 2015():891707. PubMed ID: 26301254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seven functional classes of Barth syndrome mutation.
    Whited K; Baile MG; Currier P; Claypool SM
    Hum Mol Genet; 2013 Feb; 22(3):483-92. PubMed ID: 23100323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barth syndrome mutations that cause tafazzin complex lability.
    Claypool SM; Whited K; Srijumnong S; Han X; Koehler CM
    J Cell Biol; 2011 Feb; 192(3):447-62. PubMed ID: 21300850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promotion of plasmalogen biosynthesis reverse lipid changes in a Barth Syndrome cell model.
    Bozelli JC; Lu D; Atilla-Gokcumen GE; Epand RM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158677. PubMed ID: 32126285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.
    Russo S; De Rasmo D; Signorile A; Corcelli A; Lobasso S
    Sci Rep; 2022 Nov; 12(1):19847. PubMed ID: 36400945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MCU-complex-mediated mitochondrial calcium signaling is impaired in Barth syndrome.
    Ghosh S; Zulkifli M; Joshi A; Venkatesan M; Cristel A; Vishnu N; Madesh M; Gohil VM
    Hum Mol Genet; 2022 Feb; 31(3):376-385. PubMed ID: 34494107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of branched-chain amino acid aminotransferases rescues the growth defects of cells lacking the Barth syndrome-related gene TAZ1.
    Antunes D; Chowdhury A; Aich A; Saladi S; Harpaz N; Stahl M; Schuldiner M; Herrmann JM; Rehling P; Rapaport D
    J Mol Med (Berl); 2019 Feb; 97(2):269-279. PubMed ID: 30604168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
    Ikon N; Ryan RO
    Lipids; 2017 Feb; 52(2):99-108. PubMed ID: 28070695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H
    Goncalves RLS; Schlame M; Bartelt A; Brand MD; Hotamışlıgil GS
    FEBS Lett; 2021 Feb; 595(3):415-432. PubMed ID: 33112430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barth Syndrome Cardiomyopathy: An Update.
    Pang J; Bao Y; Mitchell-Silbaugh K; Veevers J; Fang X
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome.
    Dudek J; Cheng IF; Balleininger M; Vaz FM; Streckfuss-Bömeke K; Hübscher D; Vukotic M; Wanders RJ; Rehling P; Guan K
    Stem Cell Res; 2013 Sep; 11(2):806-19. PubMed ID: 23792436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of mitophagy ameliorates cardiomyopathy in Barth syndrome.
    Zhang J; Liu X; Nie J; Shi Y
    Autophagy; 2022 Sep; 18(9):2134-2149. PubMed ID: 34985382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular functions of cardiolipin in yeast.
    Joshi AS; Zhou J; Gohil VM; Chen S; Greenberg ML
    Biochim Biophys Acta; 2009 Jan; 1793(1):212-8. PubMed ID: 18725250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental models of Barth syndrome.
    Pu WT
    J Inherit Metab Dis; 2022 Jan; 45(1):72-81. PubMed ID: 34370877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac metabolic pathways affected in the mouse model of barth syndrome.
    Huang Y; Powers C; Madala SK; Greis KD; Haffey WD; Towbin JA; Purevjav E; Javadov S; Strauss AW; Khuchua Z
    PLoS One; 2015; 10(6):e0128561. PubMed ID: 26030409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.
    Sabbah HN
    Heart Fail Rev; 2021 Mar; 26(2):237-253. PubMed ID: 33001359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barth syndrome in a female patient.
    Cosson L; Toutain A; Simard G; Kulik W; Matyas G; Guichet A; Blasco H; Maakaroun-Vermesse Z; Vaillant MC; Le Caignec C; Chantepie A; Labarthe F
    Mol Genet Metab; 2012 May; 106(1):115-20. PubMed ID: 22410210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome.
    de Taffin de Tilques M; Tribouillard-Tanvier D; Tétaud E; Testet E; di Rago JP; Lasserre JP
    Dis Model Mech; 2017 Apr; 10(4):439-450. PubMed ID: 28188263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining functional classes of Barth syndrome mutation in humans.
    Lu YW; Galbraith L; Herndon JD; Lu YL; Pras-Raves M; Vervaart M; Van Kampen A; Luyf A; Koehler CM; McCaffery JM; Gottlieb E; Vaz FM; Claypool SM
    Hum Mol Genet; 2016 May; 25(9):1754-70. PubMed ID: 26908608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome.
    Claypool SM; Boontheung P; McCaffery JM; Loo JA; Koehler CM
    Mol Biol Cell; 2008 Dec; 19(12):5143-55. PubMed ID: 18799610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.